News

The Kidney Foundation of Canada is a proud strategic partner in the Living Donor Circle of Excellence program, an internationally recognized initiative, in collaboration with the American Society of Transplantation (AST) and the Canadian Society of Transplantation (CST).

Over a career spanning more than 25 years, Dr. Tomoko Takano has won the respect and gratitude of her peers and patients for her steadfast commitment to advancing understanding and treatment of kidney disease.

Recently, the BC and Yukon Branch hosted a recognition evening for the 2025 inductees into the Living Donor Circle of Excellence (CoE).

A new analysis from the Global Burden of Disease Study published in The Lancet in November 20251, shows that the impact of chronic kidney disease (CKD) has substantially increased over the past three decades.

The Kidney Foundation launched their annual Kidney 50/50 raffle in Ontario just in time for the holiday season.

Protecting the long-term health of their heart and kidneys is a major challenge for people with type 1 diabetes (T1D). Luckily, findings from the SUGARNSALT project demonstrate medications that can help with this.

This year (2025) marks a huge milestone for the Canadian Institutes of Health Research (CIHR) as it celebrates its 25th anniversary.

For the third year in a row, the kidney community rallied together in a big way across the province raising over $1,182,000, crushing this year’s goal of $900,000.

Shining a spotlight on the extraordinary volunteers who fuel its mission, The Kidney Foundation of Canada recently took the opportunity to laud these effects during its Annual Virtual Recognition Awards.

KRESCENT is Canada’s elite kidney health research training program – supporting the next generation of kidney health researchers for the past 20 years.

You are passionate about people, you are looking for a way to help, this one is for you!

Health Canada has approved Ozempic (semaglutide) for people living with type 2 diabetes and chronic kidney disease.